CN102716389B - Externally dressed drug for treating gout - Google Patents

Externally dressed drug for treating gout Download PDF

Info

Publication number
CN102716389B
CN102716389B CN201110165020.0A CN201110165020A CN102716389B CN 102716389 B CN102716389 B CN 102716389B CN 201110165020 A CN201110165020 A CN 201110165020A CN 102716389 B CN102716389 B CN 102716389B
Authority
CN
China
Prior art keywords
parts
weight parts
gout
pain
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201110165020.0A
Other languages
Chinese (zh)
Other versions
CN102716389A (en
Inventor
王长锋
Original Assignee
王长锋
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 王长锋 filed Critical 王长锋
Priority to CN201110165020.0A priority Critical patent/CN102716389B/en
Publication of CN102716389A publication Critical patent/CN102716389A/en
Application granted granted Critical
Publication of CN102716389B publication Critical patent/CN102716389B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention, relating to the field of traditional Chinese medicine, discloses an externally dressed drug for treating gout, solving the problems of slow effect of treatment, recurrent episodes, patients in pain and the like existing in the prior art. The drug comprises the following ingredients: 2-5 weight parts of plantain seed, 2-5 weight parts of Smilax glabra Roxb., 4-10 weight parts of Eupolyphaga sinensis Walker, 5-10 weight parts of Angelica sinensis, 5-8 weight parts of dragon's blood, 5-10 weight parts of olibanum, 3-8 weight parts of Pinellia ternate, 3-7 weight parts of myrrh, 1-3 weight parts of cinnabaris, 1-5 weight parts of pillis ophidiae, and 8-15 weight parts of Panax notoginseng powder. After gout patients use the externally dressed drug, the pain is subsided obviously, the pain can be removed within three days, affected parts have no swelling, and there is no relapse after curing.

Description

The topical agent for the treatment of gout
Technical field:
The present invention relates to the field of Chinese medicines, be specially a kind of topical agent for the treatment of gout.
Background technology:
Gout claims again " hyperuricemia ", and purine metabolism obstacle belongs to arthritis one.Gout is that the metabolism of the material of purine in human body gets muddled, and the synthetic increase of uric acid or discharge reduce, and cause hyperuricemia, when serum Uric Acid Concentration is too high, uric acid is deposited in joint, cartilage and kidney with the form of sodium salt, causes and organizes foreign body inflammatory reaction, i.e. gout.
Doctor trained in Western medicine is commonly used releasing uric acid, salicylic acid and is received the medicines such as sheet, meticorten, dexamethasone, to remove wind, invigorate blood circulation as main, pain relieving is auxiliary, period in a medicine produces effect, after drug withdrawal, the state of an illness recurs again, and period in a medicine occurs with the symptom of Liver and kidney pain, and have frequent micturition, urgent micturition, the side effect such as nervous, the state of an illness is not fundamentally cured and is alleviated.
At present, the prescription for the treatment of gout is a lot, but is all can only relief of symptoms or respite mostly, and it has shortcomings:
1, treatment does not have effect;
2, patient shows effect repeatedly, agonizing;
3, effect is undesirable, and patient's folding time consuming is long.
Facts have proved, motherland's medicine and pharmacology have tired out rich experience at treatment gout prescription area, and the traditional Chinese medical science is more emphasized overall treatment, and treating both the principal and secondary aspects of a disease puts prevention first, and Chinese medicine is few and famous with untoward reaction.Therefore, this sick Chinese medicine preparation of development treatment is highly significant with necessity.
Summary of the invention:
The object of the present invention is to provide a kind of topical agent for the treatment of gout, solve the problems such as responding well to treatment of existing in prior art is slow, and patient shows effect repeatedly, agonizing.
To achieve these goals, the present invention adopts following technical scheme:
Treat a topical agent for gout, meter by weight, medicament consists of: 2~5 parts of Semen Plantaginiss, 2~5 parts of Rhizoma Smilacis Glabraes, 4~10 parts of Eupolyphaga Seu Steleophagas, 5~10 parts of Radix Angelicae Sinensis, 5~8 parts of Sanguis Draxonis, 5~10 parts of Olibanums, 3~8 parts of the Rhizoma Pinelliaes, 3~7 parts of Myrrhas, 1~3 part, Cinnabaris, 1~5 part of Periostracum Serpentis, 8~15 parts of Radix Notoginseng powder.
The topical agent of described treatment gout, meter by weight, medicament consists of: 3~5 parts of Semen Plantaginiss, 3~5 parts of Rhizoma Smilacis Glabraes, 4~6 parts of Eupolyphaga Seu Steleophagas, 6~8 parts of Radix Angelicae Sinensis, 5~7 parts of Sanguis Draxonis, 5~6 parts of Olibanums, 3~8 parts of the Rhizoma Pinelliaes, 3~7 parts of Myrrhas, 2~3 parts, Cinnabaris, 1~3 part of Periostracum Serpentis, 8~14 parts of Radix Notoginseng powder.
The topical agent of described treatment gout, meter by weight, medicament consists of: 2~3 parts of Semen Plantaginiss, 2~5 parts of Rhizoma Smilacis Glabraes, 5~10 parts of Eupolyphaga Seu Steleophagas, 5~10 parts of Radix Angelicae Sinensis, 5~8 parts of Sanguis Draxonis, 5~10 parts of Olibanums, 3~5 parts of the Rhizoma Pinelliaes, 5~7 parts of Myrrhas, 1~2 part, Cinnabaris, 3~5 parts of Periostracum Serpentiss, 10~15 parts of Radix Notoginseng powder.
The topical agent of described treatment gout, medicament is Powdered, and Radix Notoginseng powder is powdery, and granularity is about 80~150 orders, and the granularity of all the other powder is 8~12 orders.
The topical agent of described treatment gout, every secondary topical agent is got 50~80 grams.Medicament before use, is poured medicament in vinegar into and is stirred, and the part by weight of vinegar and medicament is 10: (40~60); Then with gauze parcel, pave rear use, during use, spread on gout place; During external application, medicine layer thickness is 2~3 centimetres, and area coverage is more than the twice in gout affected part, and gout affected part is positioned at the centre of medicated bag, does not need to change, and as found the dry shortage moisture of medicated bag, with 8~12ml vinegar, sprays and on medicated bag, can continue to use.
Pharmacology analysis of the present invention is as follows:
(1) Semen Plantaginis, can pain relieving, clearing away heat and promoting diuresis, and eliminating dampness by diuresis antidiarrheal, can remove pathogenic wind toxic; < < book on Chinese herbal medicine converges says > >: with the medicinal energy of relaxing muscles and tendons promoting diuresis to eliminate dampness and promoting QI circulation, the sufficient knee joint of strong fortune.
(2) Rhizoma Smilacis Glabrae, removing toxic substances, dehumidifying, sharp joint, cures mainly muscles and bones spasm and pain.< < detailed outline > >: Rhizoma Smilacis Glabrae energy strengthening the spleen and stomach, curing rheumatism, the strong battalion of taste defend from, rheumatism is gone muscles and bones profit.
(3) Eupolyphaga Seu Steleophaga, the effect of tool removing blood stasis, reunion of fractured tendons and bones, can be used for the diseases such as fracture and injury, the stagnant pain of the stasis of blood, lumbar strain.Eupolyphaga Seu Steleophaga has blood coagulation resisting function, can improve and reinforcement in the blood supply of major organs, tissue and whole body, hematoblastic aggregation rate is had to remarkable inhibitory action, that can obviously suppress exogenous ADP lures poly-effect and hematoblastic release function
(4) Radix Angelicae Sinensis, the effect of invigorating blood circulation of enriching blood, cures mainly rheumatic arthralgia, injury from falling down etc., and Radix Angelicae Sinensis is always by the traditional Chinese medical science key medicine that is considered as enriching blood, for the treatment of anemia.Can anticoagulant, antithrombotic, and have extremely significant hematosis.
(5) Sanguis Draxonis, promoting blood circulation to remove blood stasis, analgesic therapy, hemostasia and promoting granulation, cure mainly treating swelling and pain by traumatic injury, ecchymoma due to internal injury; Continuous bleeding due to traumatic injury, ecthyma unhealed for long time etc., join Myrrha, and the power of its promoting blood circulation and breaking stagnation strengthens, for traumatic injury, swelling and pain due to blood stasis.Join Olibanum, blood activating and promoting tissue regeneration, sore again, stretches muscle, therefore can be used for malignant boil carbuncle, does not close up for a long time, and incised wound is hemorrhage, and wound such as does not conform at the disease.
(6) Olibanum, controls coagulation of QI-blood, trusted subordinate's pain, carbuncle pyogenic infections from tumour or sore, traumatic injury
Olibanum compatibility Myrrha: the two all has the merit of promoting blood circulation to remove blood stasis pain relieving, detumescence and promoting granulation. but the gas pain relieving power of the pungent Wen Xiangrun of Olibanum in can promoting the circulation of blood hold concurrently by force can relaxing muscles and tendons and activating QI and blood in the collateral; The flat broken power of letting out of the loose blood of blood stasis expelling of being longer than of the arduous property of Myrrha is large. the effect that Xiang Wuwei plays promoting blood circulation to remove obstruction in the collateral, reducing swelling and alleviating pain, expelling pus and promoting granulation significantly altogether by its effect, external application be used for the treatment of skin infection burst do not hold back for a long time, the muscle of traumatic injury swells and ache
Olibanum compatibility Sanguis Draxonis: Olibanum promoting blood circulation and stopping pain detumescence; The pain relieving of Sanguis Draxonis promoting blood circulation to remove blood stasis; The congestion that Papillary has the effect of activating blood and removing stasis pain relieving to be used for the treatment of traumatic injury swells and ache
(7) Rhizoma Pinelliae, pinellin is also a kind of phytohemagglutinin, it and rabbit erythrocyte have single-minded hemagglutinative vigor.Pungent loose warm-dryness syndrome is poisonous, main enter taste double enter lung, the water of manageing it is wet, lowering the adverse flow of QI, and the kind taste damp-phlegm of dispelling.Water is wet goes the strong and sputum of spleen from disappearing, contrary gas harmonization of the stomach falls and feeling of fullness vomiting from only, therefore be drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, the good medicine of dissolving lump and resolving mass.< < herbal classic > >: main typhoid fever cold and heat, hardness in the epigastrium, the therapeutic method to keep the adverse QI flowing downwards, laryngopharynx swells and ache, and dizziness breast is swollen, cough with dyspnea, borborygmus, hidroschesis.
(8) Myrrha, has the effects such as promoting blood circulation and stopping pain, detumescence and promoting granulation, cures mainly traumatic injury, bones and muscles pain; Prevent that tissue deterioration from producing effect very much, especially have the situation of wound gangrene.Its refrigerant function can help corridor, skin ulcer and skin ulcer, can also improve the stream wound of soup and the skin of be full of cracks.Myrrha compatibility Flos Carthami Myrrha promoting blood circulation and stopping pain, Flos Carthami activating blood and removing stasis stimulates the menstrual flow. and Papillary, has the silt of invigorating blood circulation, dispel, stimulates the menstrual flow, the effect of pain relieving, by the stasis pain of become silted up in trusted subordinate's pain, dysmenorrhea, puerperal due to what treatment blood stasis resistance stomachache and traumatic injury.
(9) Cinnabaris, clear away heart-fire relieving convulsion, the removing toxic substances of calming the nerves, have calmness, syngignoscism, < < does not record > >: promoting blood circulation, stops stuffy sensation with restlessness, quenches one's thirst, benefit spirit, moistening face color, except attacked by pestiferous factors stomachache, all skin ulcers of poison scabies flaccidity.
(10) Periostracum Serpentis, has and dispels the wind, arresting convulsion, and removing toxic substances, the effect of nebula removing, containing ossein, can treat osteodynia.
(11) Radix Notoginseng powder, regulates the flow of vital energy, and astringent therapy cures mainly detumescence, traumatic injury, congestion and swelling pain, sufferings etc., and Radix Notoginseng has the title of " refreshing medicine stops blooding ", dissipating blood stasis blood, and hemostasis and do not stay the stasis of blood, to have the stagnant person of the stasis of blood concurrently more suitable to hemorrhage.Radix Notoginseng has promoting blood circulation to remove blood stasis effect, energy antiplatelet aggregation, and antithrombotic forms.In addition, Radix Notoginseng injection can significantly promote the recovery of erythrocyte, reticulocyte, hemoglobin.
Beneficial effect of the present invention:
1, patient with gout is being used after topical agent of the present invention, and pain obviously alleviates before comparatively using the present invention;
2, patient with gout is being used after topical agent of the present invention, and pain symptom can disappear for three days;
3, patient with gout is being used after topical agent of the present invention, and affected part does not have swelling phenomenon;
4, patient with gout is being used after topical agent of the present invention, no longer recurrence after healing.
The specific embodiment:
Embodiment 1
In the present embodiment, the consisting of of medicament: 3 grams of Semen Plantaginiss, 3 grams of Rhizoma Smilacis Glabraes, 8 grams of Eupolyphaga Seu Steleophagas, 8 grams of Radix Angelicae Sinensis, 6 grams of Sanguis Draxonis, 8 grams of Olibanums, 5 grams of the Rhizoma Pinelliaes, 5 grams of Myrrhas, 2 grams, Cinnabaris, 3 grams of Periostracum Serpentiss, 10 grams of Radix Notoginseng powder.Medicament before use, will stir in the medicament vinegar that to pour into by vinegar and medicament part by weight be 10: 50, then with gauze parcel, paves rear use, spreads on gout place during use; During external application, medicine layer thickness is 2-3 centimetre, and area coverage is more than the twice in gout affected part, and gout affected part is positioned at the centre of medicated bag.
Clinic Case:
Lee so-and-so, man, 56 years old, calligraphist; As noted public figure, often attend various dinner parties, usually a large amount of drinks beer, the delicious dish of the various seafood of simultaneously taking food, in the course of time, suffers from gout, and wrist hurt like hell during outbreak, can not write and write, very painful.Use the embodiment of the present invention 1 external application for curing, spray vinegar twice in 7 days, in these 7 days, affected part does not have swelling phenomenon, from starting just not occur severe pain, but mild pain, and alleviate gradually the disappearance afterwards to 7 days, do not recur so far.
Embodiment 2
In the present embodiment, the consisting of of medicament: 2 grams of Semen Plantaginiss, 5 grams of Rhizoma Smilacis Glabraes, 4 grams of Eupolyphaga Seu Steleophagas, 10 grams of Radix Angelicae Sinensis, 5 grams of Sanguis Draxonis, 10 grams of Olibanums, 3 grams of the Rhizoma Pinelliaes, 7 grams of Myrrhas, 1 gram, Cinnabaris, 5 grams of Periostracum Serpentiss, 8 grams of Radix Notoginseng powder.Medicament before use, will stir in the medicament vinegar that to pour into by vinegar and medicament part by weight be 10: 50, then with gauze parcel, paves rear use, spreads on gout place during use; During external application, medicine layer thickness is 2-3 centimetre, and area coverage is more than the twice in gout affected part, and gout affected part is positioned at the centre of medicated bag.
Clinic Case:
Guo so-and-so, man, 47 years old, certain proprietor of an establishment; Have a bright and cheerful disposition, communication extensively, moves in various occasions for a long time, and heavy drinking and simultaneously edible seafood, suffer from goat in the course of time, often falls ill agonizing, and large female toe joint redness can not be walked.Use the embodiment of the present invention 2 external application for curing, spray vinegar twice in 7 days, in these 7 days, affected part does not have swelling phenomenon, from starting just not occur severe pain, but mild pain, and alleviate gradually the disappearance afterwards to 7 days, do not recur so far; And do not affect during one's sickness on foot the processing transactions of still can going to work.
Embodiment 3
In the present embodiment, the consisting of of medicament: 5 grams of Semen Plantaginiss, 2 grams of Rhizoma Smilacis Glabraes, 10 grams of Eupolyphaga Seu Steleophagas, 5 grams of Radix Angelicae Sinensis, 8 grams of Sanguis Draxonis, 5 grams of Olibanums, 8 grams of the Rhizoma Pinelliaes, 3 grams of Myrrhas, 3 grams, Cinnabaris, 1 gram of Periostracum Serpentis, 15 grams of Radix Notoginseng powder.Medicament before use, will stir in the medicament vinegar that to pour into by vinegar and medicament part by weight be 10: 50, then with gauze parcel, paves rear use, spreads on gout place during use; During external application, medicine layer thickness is 2-3 centimetre, and area coverage is more than the twice in gout affected part, and gout affected part is positioned at the centre of medicated bag.
Clinic Case:
Zhang, man 62 years old, retirement individual; Just like at an early age to drink, old age, sons and daughters showed filal obedience, and were well off, and few drink Chinese liquor that sons and daughters advise, changes drinking beer; Near place of residence, be exactly seafood market, often fresh and alive little seafood is bought in city as early as possible, edible together with medicated beer after culinary art; After 2 years, find that large female toe swells and ache, originally eat of analgesic, also ineffective, repeatedly several times, by hospital diagnosis, be gout, multi-treatment is invalid.Use the embodiment of the present invention 3 external application for curing, in 7 days, spray vinegar twice, from finding that there is symptom, just start the timely drug of topical application, in these 7 days, affected part does not have swelling phenomenon, from starting just not occur severe pain, but mild pain, and alleviate gradually the disappearance afterwards to 7 days, do not recur so far, and do not affect during one's sickness on foot.

Claims (4)

1. a topical agent for the treatment of gout, is characterized in that, by weight meter, medicament consists of: 2~5 parts of Semen Plantaginiss, 2~5 parts of Rhizoma Smilacis Glabraes, 4~10 parts of Eupolyphaga Seu Steleophagas, 5~10 parts of Radix Angelicae Sinensis, 5~8 parts of Sanguis Draxonis, 5~10 parts of Olibanums, 3~8 parts of the Rhizoma Pinelliaes, 3~7 parts of Myrrhas, 1~3 part, Cinnabaris, 1~5 part of Periostracum Serpentis, 8~15 parts of Radix Notoginseng powder.
2. according to the topical agent for the treatment of gout claimed in claim 1, it is characterized in that, by weight meter, medicament consists of: 3~5 parts of Semen Plantaginiss, 3~5 parts of Rhizoma Smilacis Glabraes, 4~6 parts of Eupolyphaga Seu Steleophagas, 6~8 parts of Radix Angelicae Sinensis, 5~7 parts of Sanguis Draxonis, 5~6 parts of Olibanums, 3~8 parts of the Rhizoma Pinelliaes, 3~7 parts of Myrrhas, 2~3 parts, Cinnabaris, 1~3 part of Periostracum Serpentis, 8~14 parts of Radix Notoginseng powder.
3. according to the topical agent for the treatment of gout claimed in claim 1, it is characterized in that, by weight meter, medicament consists of: 2~3 parts of Semen Plantaginiss, 2~5 parts of Rhizoma Smilacis Glabraes, 5~10 parts of Eupolyphaga Seu Steleophagas, 5~10 parts of Radix Angelicae Sinensis, 5~8 parts of Sanguis Draxonis, 5~10 parts of Olibanums, 3~5 parts of the Rhizoma Pinelliaes, 5~7 parts of Myrrhas, 1~2 part, Cinnabaris, 3~5 parts of Periostracum Serpentiss, 10~15 parts of Radix Notoginseng powder.
4. according to the topical agent for the treatment of gout claimed in claim 1, it is characterized in that, medicament is Powdered, and Radix Notoginseng powder is powdery, and granularity is 80~150 orders, and the granularity of all the other powder is 8~12 orders.
CN201110165020.0A 2011-06-20 2011-06-20 Externally dressed drug for treating gout Expired - Fee Related CN102716389B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110165020.0A CN102716389B (en) 2011-06-20 2011-06-20 Externally dressed drug for treating gout

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110165020.0A CN102716389B (en) 2011-06-20 2011-06-20 Externally dressed drug for treating gout

Publications (2)

Publication Number Publication Date
CN102716389A CN102716389A (en) 2012-10-10
CN102716389B true CN102716389B (en) 2014-04-30

Family

ID=46942344

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110165020.0A Expired - Fee Related CN102716389B (en) 2011-06-20 2011-06-20 Externally dressed drug for treating gout

Country Status (1)

Country Link
CN (1) CN102716389B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106606526A (en) * 2015-10-15 2017-05-03 北京久易生科技有限公司 Traditional Chinese medicine externally applied agent composition for treating gout

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1657087A (en) * 2004-02-16 2005-08-24 常为忠 Medicinal composition for treating rheumatism atrophic arthritis
CN1814247A (en) * 2005-11-22 2006-08-09 田茂宁 Chinese medicine bone-setting ointment and preparing method
WO2007075255A2 (en) * 2005-12-27 2007-07-05 Intact Enterprises, Inc. Mastic gum composition for use as a dietary supplement in humans and animals
CN101264205A (en) * 2008-04-25 2008-09-17 北京中泰天和科技有限公司 Chinese medicinal composition for treating gout and preparation thereof
WO2008112561A1 (en) * 2007-03-09 2008-09-18 Pfantastic Medical Research Institute, Llc Combination therapy for alleviating pain-related conditions
CN101428121A (en) * 2007-11-06 2009-05-13 赵淑珍 Traditional Chinese medicine liniment for activating blood circulation and removing stasis, dispersing the swelling, relieving pain, relaxing tendons and activating collaterals

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1657087A (en) * 2004-02-16 2005-08-24 常为忠 Medicinal composition for treating rheumatism atrophic arthritis
CN1814247A (en) * 2005-11-22 2006-08-09 田茂宁 Chinese medicine bone-setting ointment and preparing method
WO2007075255A2 (en) * 2005-12-27 2007-07-05 Intact Enterprises, Inc. Mastic gum composition for use as a dietary supplement in humans and animals
WO2008112561A1 (en) * 2007-03-09 2008-09-18 Pfantastic Medical Research Institute, Llc Combination therapy for alleviating pain-related conditions
CN101428121A (en) * 2007-11-06 2009-05-13 赵淑珍 Traditional Chinese medicine liniment for activating blood circulation and removing stasis, dispersing the swelling, relieving pain, relaxing tendons and activating collaterals
CN101264205A (en) * 2008-04-25 2008-09-17 北京中泰天和科技有限公司 Chinese medicinal composition for treating gout and preparation thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
何绍奇.痛风.《现代中医内科学》.中国医药科技出版,1991,第428页. *

Also Published As

Publication number Publication date
CN102716389A (en) 2012-10-10

Similar Documents

Publication Publication Date Title
CN104367911B (en) Treat Chinese medicine composition of rheumatism and rheumatoid arthritis and preparation method thereof
CN103330826B (en) Traditional Chinese medicine composition for treating deficiency of lung yin
CN104857188A (en) Traditional Chinese medicine composite for treating edema
CN104491642A (en) Foot bath powder for preventing and treating gout
CN104107393A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis
CN102716389B (en) Externally dressed drug for treating gout
CN103638475A (en) Traditional Chinese medicinal spray for treating lump in breast and preparation method thereof
CN105582154A (en) Capsule medicine for treating wind cold induced migraine and preparation method
CN103610831B (en) A kind of Chinese medicine for the treatment of neck and shoulder pain
CN103623111B (en) Traditional Chinese medicine for treating urticaria
CN105663851A (en) Traditional Chinese medicine composition for treating oral ulcer
CN105147855A (en) Externally applied ointment for treating skin eczema
CN102349957A (en) Traditional Chinese medicine composition for treating prurigo
CN105031595A (en) Traditional Chinese medicine tablet for treating nummular eczema and preparing method thereof
CN104257986A (en) Traditional Chinese medicine for treating nephritis
CN103623263A (en) Compound traditional Chinese medicine for treating tinea corporis
CN104161996A (en) Combined medicine for treating traumatic injury and preparation method of combined medicine
CN103961490A (en) Compound medicine for treating wind-cold-dampness arthralgia and preparation method thereof
CN103550471A (en) Traditional Chinese medicine (TCM) composition for treating Bi pain
CN103933389B (en) Traditional Chinese medicine composition for treating ovarian cyst
CN103316099A (en) Gynecologic inflammation treatment spray
CN103393871A (en) Externally used medicinal liquor for treating rheumatism, arthralgia and traumatic injury
CN106943476A (en) It is a kind of to be used to treat decoction medicine of eczema and preparation method thereof
CN106860652A (en) A kind of decoction medicine for treating eczema and preparation method thereof
CN103099999B (en) Traditional Chinese medicine for treating gout disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140430

Termination date: 20180620